Inventor · disambiguated record
George J. Todaro
Also filed as: TODARO GEORGE · TODARO GEORGE J
25 granted patents·2 pending applications·492 citations·filing 1984–2025
97Inventor score
Top patents by PatentIndex Score
27 records- 0187US4816561ABiologically active polypeptidesTODARO GEORGE J·Filed 1985·Granted Mar 28, 1989·59 cites·12 claims
- 0282US4863899ABiologically active polypeptidesTODARO GEORGE J·Filed 1987·Granted Sep 5, 1989·47 cites·44 claims
- 0381US5240912ATransforming growth factor (TGF) peptidesTODARO GEORGE J·Filed 1991·Granted Aug 31, 1993·64 cites·27 claims
- 0480US12247069B2Use of TGF-alpha polypeptide or anti-TGF-alpha antibodies for the treatment of diseases and disordersTODARO GEORGE J·Filed 2022·Granted Mar 11, 2025·0 cites·12 claims
- 0575US4645828APlatelet related growth regulatorONCOGEN·Filed 1985·Granted Feb 24, 1987·33 cites·4 claims
- 0675US2025179165A1Use of tgf-alpha polypeptide or anti-tgf-alpha antibodies for the treatment of diseases and disordersTODARO GEORGE J·Filed 2025·Application pending·0 cites
- 0773US5786349AMethod for treating chlamydia infectious diseases by rifamycin derivativeKANEKA CORP·Filed 1996·Granted Jul 28, 1998·40 cites·14 claims
- 0873US4708948ASubstantially purified tumor growth inhibitory factorUS HEALTH·Filed 1984·Granted Nov 24, 1987·31 cites·2 claims
- 0969US11279753B2Use of TGF-alpha polypeptide or anti-TGF-alpha antibodies for the treatment of diseases and disordersTODARO GEORGE J·Filed 2019·Granted Mar 22, 2022·0 cites·16 claims
- 1066US4816442AMethod of inhibiting tumor growth sensitive to CIF-βtreatmentCOLLAGEN CORP·Filed 1986·Granted Mar 28, 1989·15 cites·3 claims
- 1164US4590003APlatelet related growth regulatorONCOGEN·Filed 1984·Granted May 20, 1986·17 cites·5 claims
- 1263US6171824B1Hybrid cytokinesHUTCHINSON FRED CANCER RES·Filed 1993·Granted Jan 9, 2001·20 cites·33 claims
- 1363US5248666AMethods for inhibiting neoplastic cell proliferation using platelet factor 4ONCOGEN·Filed 1992·Granted Sep 28, 1993·18 cites·2 claims
- 1463US2019375833A1Use of tgf-alpha polypeptide or anti-tgf-alpha antibodies for the treatment of diseases and disordersTODARO GEORGE J·Filed 2019·Application pending·0 cites
- 1561US6204364B1Hybrid cytokinesFRED HUTCHINSON RES CT·Filed 1993·Granted Mar 20, 2001·21 cites·16 claims
- 1661US4774318ASnake venom growth arresting peptideONCOGEN·Filed 1987·Granted Sep 27, 1988·15 cites·7 claims
- 1760US4737580APlatelet related growth regulatorONCOGEN·Filed 1986·Granted Apr 12, 1988·18 cites·2 claims
- 1855US5925733ADNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosisUNIV WASHINGTON·Filed 1996·Granted Jul 20, 1999·10 cites·7 claims
- 1954US4880512APulsed light selective photolysis process for treatment of biological media and products made therebyKOLLMORGEN CORP·Filed 1988·Granted Nov 14, 1989·41 cites·55 claims
- 2053US4714683APolypeptide tumor inhibitors and antibodies theretoONCOGEN·Filed 1985·Granted Dec 22, 1987·9 cites·18 claims
- 2152US4806492APolypeptide tumor inhibitors and antibodies theretoONCOGEN INC·Filed 1985·Granted Feb 21, 1989·5 cites·9 claims
- 2249US4731439ASnake venom growth arresting peptideONCOGEN·Filed 1985·Granted Mar 15, 1988·8 cites·8 claims
- 2339US5077312ABiologically active lipids binding membrane receptorsONCOGEN·Filed 1990·Granted Dec 31, 1991·7 cites·2 claims
- 2438US5011777AVectors encoding brain derivable polypeptide factorsONCOGEN·Filed 1990·Granted Apr 30, 1991·6 cites·6 claims
- 2535US5093045ABiologically active lipids binding membrane receptorsONCOGEN·Filed 1990·Granted Mar 3, 1992·4 cites·2 claims
- 2634US4963485ABrain derivable polypeptide factors and antibodies theretoONCOGEN·Filed 1986·Granted Oct 16, 1990·3 cites·48 claims
- 2731US4990289ABiologically active lipids binding membrane receptorsONCOGEN·Filed 1986·Granted Feb 5, 1991·1 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when George J. Todaro files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →